Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria

Lisandro D. Colantonio, Keri L. Monda, Robert S. Rosenson, Todd M. Brown, Katherine E. Mues, George Howard, Monika M. Safford, Larisa Yedigarova, Michael E. Farkouh, Paul Muntner

Cardiovascular Drugs and Therapy · 2019 · 16 citations · 29 references

Concepts

References

29